Pharma Marketing Network

This article, however, tells the Tale of Two Books: Bad Pharma, a 430-page book by Ben Goldacre, a British physician, whose previous book, Bad Science, was a best seller in the 'non-fiction' realm and the much smaller 123-page book Devalued and Distrusted by John L. LaMattina, former president of research and develop at Pfizer.

To usher in the New Year, it's traditional for pundits like Pharmaguy (aka John Mack, Publisher of Pharma Marketing News) to go out on a limb and make a few pharma industry predictions for the year.

It's appropriate that I present a few pharma industry predictions for 2013 in the last post of the year to Pharma Marketing Blog. To compile the...

A month ago, I wrote an "open letter" to Megan Clark Velez, MPH, Office of the FDA Commissioner, asking her for more transparency regarding...

My Twitter pal Henry Gazay, CEO, Medimix International, is at it again. He's compiling the #pharma100 crowdsourced list of the top100 Social media pharma...

Welcome to Volume 11, Issue #11 (27 December 2012) of Pharma Marketing News.

Thanks to everyone wishing me "Happy Holidays," including "Professor Syrum" from Boehringer Ingelheim's Syrum Facebook game. The good Prof sent me this e-mail holiday...

The authors of a scientific statement published in the American Heart Association (AHA) journal, Circulation, cited an analysis of the Framingham Heart Study, which...

As we learn more about the young man who killed 20 grade school children and 6 adults in Newtown, CT, a few issues have...

Have you seen this press release? "Philips Survey Reveals One in 10 Americans Believe Online Health Information Saved Their Life" A recent U.S. survey commissioned by...